Cargando…
Outcomes in infants < 29 weeks of gestation following single-dose prophylactic indomethacin
BACKGROUND: Prophylactic indomethacin (3 doses) decreases patent ductus arteriosus (PDA) and intraventricular hemorrhage (IVH) in preterm infants. The study aim was to determine whether single-dose indomethacin (SD-INDO) decreases PDA, IVH, and improves motor function. METHODS: A retrospective cohor...
Autores principales: | Gillam-Krakauer, Maria, Slaughter, James C., Cotton, Robert B., Robinson, Blaine E., Reese, Jeff, Maitre, Nathalie L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7499931/ https://www.ncbi.nlm.nih.gov/pubmed/32948814 http://dx.doi.org/10.1038/s41372-020-00814-9 |
Ejemplares similares
-
Effects of prophylactic indomethacin on morbidity and mortality in infants <25 weeks’ gestation: a protocol driven intention to treat analysis
por: Clyman, Ronald I., et al.
Publicado: (2022) -
Fluid Restriction and Prophylactic Indomethacin in Extremely Low Birth Weight Infants
por: Anabrees, Jasim A., et al.
Publicado: (2012) -
Use of Prophylactic Indomethacin in Preterm Infants: A Systematic Review and Meta-Analysis
por: Al-matary, Abdulrahman, et al.
Publicado: (2022) -
Timing of Systemic Steroids and Neurodevelopmental Outcomes in Infants < 29 Weeks Gestation
por: Kandraju, Hemasree, et al.
Publicado: (2022) -
Fetal, Infant and Maternal Outcomes among Women with Prolapsed Membranes Admitted before 29 Weeks Gestation
por: Robertson, Julie E., et al.
Publicado: (2016)